Appendicitis
Drug research and approvals for appendicitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 17, 2026, 34 studies of appendicitis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 4 drug trials for it since 2013.
- Recruiting worldwide: 34
- Trials authorized in Canada: 4
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 34 recruiting on ClinicalTrials.gov ↗- Video-Based Grading of Intraoperative Adverse Events in Pediatric Laparoscopic AppendectomyNCT07794618 · Not reported · Ahmet Burak Doğan, MD · starts Sep 1, 2026
- Prospective Comparison of Pro-Adrenomedullin, C-Reactive Protein, and Neutrophil-to-Lymphocyte Ratio for Diagnosing…NCT07889544 · Not reported · Bursa Yuksek Ihtisas Training and Research Hospital · starts Aug 1, 2026
- Systemic and Tissue Inflammatory Biomarkers in Acute AppendicitisNCT07926165 · Not reported · Haydarpasa Numune Training and Research Hospital · starts Jul 12, 2026
- Effect of Endotracheal Tube Cuff Pressure Management on Postoperative Sore Throat in Pediatric Laparoscopic AppendectomyNCT07678086 · Not applicable · Ankara Etlik City Hospital · starts Jun 30, 2026
- Oral Lactulose for Gastrointestinal Recovery After Complex AppendectomyNCT07589465 · Not applicable · Nanchong Central Hospital · starts Jun 21, 2026
- Feasibility and Safety of a Pediatric ERAS Protocol for Laparoscopic AppendectomyNCT07643285 · Not applicable · Ahmet Burak Doğan, MD · starts Jun 15, 2026
- Effect Of Specimen Extraction Site And Local Anesthesia On Postoperative Pain In Laparoscopic AppendectomyNCT07824908 · Not applicable · YUNUS YÜKSEL · starts Apr 24, 2026
- Diagnosis of Abdominal Pain Using RNA Levels: The NATURAL StudyNCT07579312 · Not reported · True Bearing Diagnostics, Inc. · starts Apr 17, 2026
- Comparison of Diagnostic Methods in Patients Operated for Suspected AppendicitisNCT07496723 · Not reported · Sanliurfa Education and Research Hospital · starts Mar 18, 2026
- Direct Visualization ERAT Versus Laparoscopic Appendectomy in Adults With Acute Uncomplicated AppendicitisNCT07230379 · Not applicable · Changhai Hospital · starts Dec 10, 2025
Drug Pipeline
2 approved, 1 in phase 3, 15 in phase 2, 2 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this conditionApproved: Tazobactam, Piperacillin
- Doripenem
- Phase 3 Bacterial penicillin-binding protein inhibitor
- Metronidazole
- Phase 2 DNA inhibitor
- Bupivacaine
- Phase 2 Sodium channel protein type IV alpha subunit blocker
- Fosfomycin
- Phase 2 UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
- Ertapenem
- Phase 2 Bacterial penicillin-binding protein inhibitor
- Ropivacaine
- Phase 2 Sodium channel alpha subunit blocker
- Sulfur hexafluoride
- Phase 2 Diagnostic agent
- Dexamethasone
- Phase 2 Glucocorticoid receptor agonist
- Cefuroxime
- Phase 2 Bacterial penicillin-binding protein inhibitor
- Ceftriaxone
- Phase 2 Bacterial penicillin-binding protein inhibitor
- Cefotaxime
- Phase 2 Bacterial penicillin-binding protein inhibitor
- Meropenem
- Phase 2 Bacterial penicillin-binding protein inhibitor
- Levofloxacin anhydrous
- Phase 2 DNA gyrase inhibitor
- Epinephrine
- Phase 2 Adrenergic receptor agonist
- Regramostim
- Phase 2 Granulocyte colony stimulating factor receptor agonist
- Povidone-iodine
- Phase 2
- Ketamine
- Early phase 1 Glutamate [NMDA] receptor negative allosteric modulator
- Cefdinir
- Early phase 1 Bacterial penicillin-binding protein inhibitor
How Its Trials Ended
363 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 72 whose ending is known, 54% met their primary endpoint, 6% missed it and 40% stopped early.
- Completed, result not reported17247%
- Ongoing6017%
- Status unknown5916%
- Met its primary endpoint3911%
- Stopped: other or unclear164%
- Stopped: enrollment or feasibility92%
- Missed its primary endpoint41%
- Stopped: lack of efficacy21%
- Stopped: sponsor or business decision10%
- Stopped: funding10%
Trials Authorized in Canada
Newest first; search them all in Canada trials| Apr 12, 2024 | Assessing the longitudinal outcomes of piperacillin/tazobactam versus ceftriaxone and metronidazole for children with perforated appendicitis (alpaca): a…metronidazole/ ceftriaxone/piperacillin-tazobactam | Mcmaster Childrens Hospital | Pending |
| Nov 1, 2023 | Intravenous ketorolac vs. morphine in children presenting with suspected appendicitis: study protocol for multicenter non-inferiority randomized controlled…Ketorolac / morphine | Governors Of The University Of Calgary | Ongoing |
| Nov 25, 2020 | Intravenous ketorolac in children presenting with suspected appendicitis: a pilot single center randomised placebo controlled trial (keto-app)Ketorolac / morphine | Hamilton Health Sciences Corporation | Ongoing |
| May 4, 2015 | Metronidazole every 24 hours as part of triple antibiotic therapy for ruptured appendicitis in children managed operatively (metro): a noninferiority…Metronidazole | Childrens Hospital Of Eastern Ontario | Pending |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA